Dr Razaghi is conducting research in translational medicine with a speciality in exploring selenium-based chemotherapeutics and cytokines for cancer treatment.
The objective of my studies is to investigate how selenotherapy (selenium-based chemotherapeutic) in combination with cytokine therapy (e.g. IFNα, IFNγ and IL2) can benefit cancer patients. The research is performed from the preclinical stage to clinical trials.
PhD: James Cook University, Queensland, Australia
MSc: University of Gothenburg (Göteborg, Sweden) and Leibniz University of Hanover (Hanover, Germany)